Clinical Predictors of Outcome in MPN

Sep 16, 2017 by in HEMATOLOGY Comments Off on Clinical Predictors of Outcome in MPN

Myeloproliferative neoplasms include 3 diseases: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). PV and ET are dominated by a high risk of thrombosis and a late risk…

read more

Myeloproliferative Neoplasm Animal Models

Sep 16, 2017 by in HEMATOLOGY Comments Off on Myeloproliferative Neoplasm Animal Models

Myeloproliferative neoplasm (MPN) animal models accurately re-capitulate human disease in mice and have been an important tool for the study of MPN biology and therapy. Transplantation of BCR-ABL transduced bone…

read more

Role of Germline Genetic Factors in MPN Pathogenesis

Sep 16, 2017 by in HEMATOLOGY Comments Off on Role of Germline Genetic Factors in MPN Pathogenesis

It is thought that myeloproliferative neoplasms (MPNs) are driven by somatic mutations, although hereditary factors also play a prominent role in the pathogenesis of the disease. Hereditary thrombocytosis and erythrocytosis…

read more

Merkel Cell Carcinoma

Sep 16, 2017 by in HEMATOLOGY Comments Off on Merkel Cell Carcinoma

Merkel cell carcinoma (MCC) is a rare but aggressive carcinoma of the skin, arising most commonly in sun-exposed sites of elderly patients. The diagnosis is based on characteristic histopathologic features….

read more

Urethral Cancer

Sep 16, 2017 by in HEMATOLOGY Comments Off on Urethral Cancer

Urethral carcinoma is a rare tumor with predominantly poor survival. Both the disease and its treatment can affect both sexual and urinary function. The natural history of urethral carcinoma varies,…

read more
Get Clinical Tree app for offline access